Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.48 |
| ▸ | LMNA | P02545 | 6/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | PKM | P14618 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | PADI1 | Q9ULC6 | 1/20 | 0.40 |
| ▸ | PADI3 | Q9ULW8 | 1/20 | 0.40 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.40 |
| ▸ | PADI2 | Q9Y2J8 | 1/20 | 0.40 |
| ▸ | CCR1 | P32246 | 3/20 | 0.40 |
| ▸ | CCR5 | P51681 | 3/20 | 0.40 |
| ▸ | CCR8 | P51685 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10307289 | 0.95 | KDM4E (0.42) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834320 | 0.91 | KDM4E (0.43) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL835331 | 0.90 | KDM4E (0.42) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL828964 | 0.89 | KDM4E (0.47) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834539 | 0.88 | KDM4E (0.46) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834325 | 0.88 | KDM4E (0.46) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834591 | 0.88 | KDM4E (0.46) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834306 | 0.87 | GRM5 (0.50) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834328 | 0.82 | PDK2 (0.37) | KDM4ELMNASMN1; SMN2TP53PKM | |
| SCHEMBL834576 | 0.82 | GRM5 (0.50) | KDM4ELMNASMN1; SMN2TP53PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | KDM4E 2122/4885LMNA 1673/4885SMN1; SMN2 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.